Patents by Inventor Thomas Norling

Thomas Norling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9067032
    Abstract: The present invention regards a novel administration form and a novel administration regime useful in the treatment and prevention of a bacterial lung infection in patient in need thereof, in particular by providing a composition useful for aerosolization of a highly concentrated solution of aminoglycosides such as Tobramycin.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: June 30, 2015
    Assignee: XELLIA PHARMACEUTICALS APS
    Inventor: Thomas Norling
  • Publication number: 20140041654
    Abstract: The present invention regards a novel administration form and a novel administration regime useful in the treatment and prevention of a bacterial lung infection in patient in need thereof, in particular by providing a composition useful for aerosolization of a highly concentrated solution of aminoglycosides such as Tobramycin.
    Type: Application
    Filed: September 30, 2013
    Publication date: February 13, 2014
    Applicant: XELLIA PHARMACEUTICALS APS
    Inventor: Thomas Norling
  • Patent number: 8598131
    Abstract: The present invention regards a novel administration form and a novel administration regime useful in the treatment and prevention of a bacterial lung infection in patient in need thereof, in particular by providing a composition useful for aerosolization of a highly concentrated solution of aminoglycosides such as Tobramycin.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: December 3, 2013
    Assignee: Xellia Pharmaceuticals APS
    Inventor: Thomas Norling
  • Publication number: 20120010162
    Abstract: The present invention regards a novel administration form and a novel administration regime useful in the treatment and prevention of a bacterial lung infection in patient in need thereof, in particular by providing a composition useful for aerosolization of a highly concentrated solution of aminoglycosides such as Tobramycin.
    Type: Application
    Filed: July 8, 2011
    Publication date: January 12, 2012
    Applicant: XELLIA PHARMACEUTICALS APS
    Inventor: Thomas Norling